ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SNYL Sunnylife Global Inc (CE)

0.000001
0.00 (0.00%)
23 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Sunnylife Global Inc (CE) USOTC:SNYL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Sunnylife Global Names Dr. Leonard Makowka as International Medical Director

24/10/2007 2:00pm

PR Newswire (US)


Sunnylife Global (CE) (USOTC:SNYL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Sunnylife Global (CE) Charts.
LOS ANGELES, Oct. 24 /PRNewswire-FirstCall/ -- Sunnylife Global, Inc. (Pink Sheets: SNYL) has announced the appointment of Leonard Makowka, M.D., Ph.D. as the company's international medical director. Dr. Makowka is a distinguished surgical transplant specialist, researcher, and leading authority in hepatic science (the science of liver functions). He successfully performed medical history's first pig-to-human liver xenograft transplantation. The former chairman of the Department of Surgery at Cedars-Sinai medical center in Los Angeles and the former Vice-Chairman, Department of Surgery at the UCLA School of Medicine, Dr. Makowka is the only two-time recipient of the Royal College of Physicians and Surgeons of Canada Medal in Surgery. At Sunnylife, Dr. Makowka will oversee the company's medical and research science initiatives. "We are thrilled and fortunate to have Dr. Makowka as a member of Sunnylife's leadership. His astounding achievements and unparalleled skills will provide our company with enormous advantages as we implement our healthcare systems in the People's Republic of China," stated Richard Lo, Sunnylife's President and Chairman. The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and 10-K. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise. FOR FURTHER INFORMATION, CONTACT: Devon Blaine The Blaine Group 310/360-1499 310/360-1498 (FAX) DATASOURCE: Sunnylife Global, Inc. CONTACT: Devon Blaine of The Blaine Group, +1-310-360-1499, fax, +1-310-360-1498, , for Sunnylife Global, Inc.

Copyright

1 Year Sunnylife Global (CE) Chart

1 Year Sunnylife Global (CE) Chart

1 Month Sunnylife Global (CE) Chart

1 Month Sunnylife Global (CE) Chart

Your Recent History

Delayed Upgrade Clock